Full Press Release Details
dupixent dupilumab late breaking data at aad show significant improvements in signs and symptoms of moderate to severe atopic hand and foot dermatitis.
REGN
dupixent dupilumab late breaking data at aad show significant improvements in signs and symptoms of moderate to severe atopic hand and foot dermatitis
Key Takeaway: dupixent dupilumab late breaking data at aad show significant improvements in signs and symptoms of moderate to severe atopic hand and foot dermatitis